Showing results (1531-1540 of 10,079) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|June 19, 2013
Non-covalent interactions with aromatic rings: current understanding and implications for rational drug designShanshan Li, Yuan Xu, Qiancheng Shen, et al.Current Pharmaceutical Design|June 21, 2013
Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugsKoji Takeuchi, Chitose Izuhara, Shinichi Takayama, et al.Current Pharmaceutical Design|June 21, 2013
Skin manifestations in course of celiac disease: case report and review of the literatureNevena Skroza, Ilari Proietti, Nicoletta Bernardini, et al.Current Pharmaceutical Design|June 21, 2013
Gut inflammation: current update on pathophysiology, molecular mechanism and pharmacological treatment modalitiesKlára Gyires, Éva Viktória Tóth, Sándor Zoltán ZádoriCurrent Pharmaceutical Design|June 25, 2013
Targeting CNS transporters for treatment of neurodegenerative diseasesGabriele Jedlitschky, Markus Grube, Igor Mosyagin, et al.Current Pharmaceutical Design|May 25, 2013
RNAi in PlasmodiumAnn-Kristin Mueller, Christiane Hammerschmidt-Kamper, Annette KaiserCurrent Pharmaceutical Design|May 25, 2013
Hydrogen peroxide produced by mitochondrial monoamine oxidase catalysis: biological implicationsDale E EdmondsonCurrent Pharmaceutical Design|May 25, 2013
Biocomputational resources useful for drug discovery against compartmentalized targetsFrancisca Sánchez-Jiménez, Armando Reyes-Palomares, Aurelio A Moya-García, et al.Current Pharmaceutical Design|May 25, 2013
Mitochondrial permeability transition as target of anticancer drugsLisa Dalla Via, Aida N García-Argáez, Mariano Martínez-Vázquez, et al.Current Pharmaceutical Design|May 25, 2013
Mitochondria-targeted resveratrol derivatives act as cytotoxic pro-oxidantsNicola Sassi, Andrea Mattarei, Michele Azzolini, et al.Pageof 1,008